| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.67 | 0.02 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |